CT-1（KSQ Therapeutics）

N/A

Report date: 2022/12/26 14:43:51

Base Information

Drug NameCT-1（KSQ Therapeutics）

Drug Alias NameCT-1（KSQ Therapeutics）

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKSQ Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesKSQ Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A